KOMU-TVCancer patient "grateful" for immunotherapy; new study shows its promiseKOMU-TVShe was then introduced to Dr. Sindhu Singh, an oncologist at MU Hospital, who finally offered a treatment that Wright was on board with: immunotherapy. &qu… Continue reading
EurekAlert (press release)Taking CRISPR from clipping scissors to word processorEurekAlert (press release)In work that will help make the gene-editing process more precise, researchers at the Joint Institute of Metrology and Biology (JIMB, a collaborat… Continue reading
|
Brainstorm Health: Athenahealth Bid, Obamacare Fast Food Rules, $1.5 Million Gene Therapy
Fortune Happy Monday, readers. I hope you had a wonderful weekend—this is Sy. Paul Singer’s activist hedge fund Elliott Management has its sights set on a new target: Athenahealth, the medical software, health IT, and data analytics firm run by CEO Jonathan … |
Fortune |
Brainstorm Health: Athenahealth Bid, Obamacare Fast Food Rules, $1.5 Million Gene Therapy
Fortune A $1.5 million gene therapy? Gene therapies that, in effect, cure or vastly improve the blood clotting disorder hemophilia (and perhaps aren’t too far from the market) could come with astronomical, record-shattering price tags, Leerink analysts argued … Paul Singer’s Elliott makes all-cash offer for Athenahealth of $160 a shareCNBC May 7, 2018 The Board of Directors athenahealth, Inc. 311 Arsenal Street Watertown, MA 02472 Dear … – Elliott LettersElliott Letters Why Athenahealth and Former GE CEO Jeff Immelt Need Each OtherFortune Press Releases | athenahealth | Press Release all 109 news articles » |
WFMZ Allentown |
Health Beat: Seeing is believing: Stem cell therapy
WFMZ Allentown MIAMI – Alison Milianta lost her vision due to a brain tumor a few years ago. “You panic. It’s almost like you’re in an earthquake. It’s like everything is closing in on you,” Milianta said. That’s when she found Dr. Jeffrey Weiss, a retinal specialist … |
EurekAlert (press release) |
New CRISPR technology ‘knocks out’ yeast genes with single-point precision
EurekAlert (press release) CHAMPAIGN, Ill. — The CRISPR-Cas9 system has given researchers the power to precisely edit selected genes. Now, researchers have used it to develop a technology that can target any gene in the yeast Saccharomyces cerevisiae and turn it off by deleting … |